MRTFA and systemic sclerosis: The activity of MRTF-A increase in a time-dependent manner during scleroderma (systemic sclerosis, SSc), and lower expression of MRTF-A or any hindrance in nuclear translocation may affect the development of fibrosis in SSc skin [54].